# clm_FE9AB4A6BF09

subject: Merck & Co. (/record/merck.md)  
predicate: quarterly_research_and_development  
value: 2,189,000,000 United States dollar  
valid_from: 2019-06-30  
valid_to: 2019-09-30  
published: 2019-08-06  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_B868BDC6CD31  
last_updated: 2026-11-08  
cite: AsOf. "Merck & Co. quarterly research and development: 2,189,000,000 United States dollar", as of 2019-06-30 (until 2019-09-30). Claim clm_FE9AB4A6BF09, https://asof.is/claim/clm_FE9AB4A6BF09, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015819000037/0000310158-19-000037-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:ResearchAndDevelopmentExpense in 10-Q Q2 FY2019, filed 2019-08-06  

## Sources

- https://www.sec.gov/Archives/edgar/data/310158/000031015819000037/0000310158-19-000037-index.htm (primary, SEC EDGAR 10-Q Q2 FY2019, published 2019-08-06)

## Supersedes

- [Merck & Co.](/record/merck.md) | quarterly_research_and_development | 1,931,000,000 United States dollar | valid 2019-03-31 to 2019-06-30 | conf 0.95 | superseded | superseded_by [clm_FE9AB4A6BF09](/claim/clm_FE9AB4A6BF09.md) | [clm_3122AF3523E0](/claim/clm_3122AF3523E0.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.